The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
Zhonghua Wang(Shenyang Pharmaceutical University)
Cited by 185
Related Papers
Efficacy and mechanism of the combination of PARP and CDK4/6 inhibitors in the treatment of triple-negative breast cancer
|Journal of Experimental & Clinical Cancer Research|2021|89